Effects of a sodium glucose co-transporter 2 selective inhibitor, ipragliflozin, on the diurnal profile of plasma glucose in patients with type 2 diabetes: A study using continuous glucose monitoring (Q36232787)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Effects of a sodium glucose co-transporter 2 selective inhibitor, ipragliflozin, on the diurnal profile of plasma glucose in patients with type 2 diabetes: A study using continuous glucose monitoring
scientific article

    Statements

    Effects of a sodium glucose co-transporter 2 selective inhibitor, ipragliflozin, on the diurnal profile of plasma glucose in patients with type 2 diabetes: A study using continuous glucose monitoring (English)
    Kentaro Yamada
    Hitomi Nakayama
    Satoko Yoshinobu
    Seiko Kawano
    Munehisa Tsuruta
    Masayuki Nohara
    Rika Hasuo
    Shoko Akasu
    Ichiro Tokubuchi
    Nobuhiko Wada
    Saori Hirao
    Shinpei Iwata
    Hiroo Kaku
    Yuji Tajiri
    20 June 2015
    699-707

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit